Molecular diagnostic testing for infectious diseases using TMA technology
Related Experiment Video
Updated: Oct 2, 2026

A Next-generation Tissue Microarray (ngTMA) Protocol for Biomarker Studies
Published on: September 23, 2014
1Gen-Probe, Inc., 10210 Genetic Center Dr., San Diego, CA 92121, USA. Craigh@gen-probe.com
Abstract:
Molecular diagnostic tests based on nucleic acid amplification technologies (NAATs) have become widely established in clinical microbiology laboratories in recent years. The acceptance of these tests has been driven by the development of more accurate and less labor-intensive commercial assay kits by diagnostic manufacturers. Infectious disease diagnostic assays using transcription-mediated amplification (TMA) NAAT have become increasingly popular in many clinical microbiology laboratories. Recent technology developments have improved the performance and simplified the use of the TMA assays. These new technologies have been applied to the development of multiplex TMA tests to improve the testing accuracy for organisms, such as Chlamydia trachomatis and Neisseria gonorrhoeae in clinical microbiology laboratories. TMA tests for HIV-1 and HCV have also led to improvements in blood bank testing which can improve the safety of the public blood supply.
Related Concept Videos
Rapid Identification of Pathogens
Automated Microbial Diagnostics
Modern Molecular Taxonomy
MALDI-TOF Mass Spectrometry
Applications of Molecular Taxonomy
Methods of Classification and Identification
